American Medical Systems Holdings, Inc. (AMMD) recently announced positive results from three major clinical studies that demonstrated high efficiency and patient satisfaction with the company’s minimally invasive treatment options for female stress urinary incontinence (SUI) and vaginal prolapse. The results also demonstrated low post-operative pain and a low incidence of adverse events for patients.

The clinical studies were concentrated on three products – the MiniArc Single-Incision Sling System for treating female SUI, the Elevate Prolapse Repair System and the Perigee Prolapse Repair System. Results for each of these studies are presented here:

• Six-month prospective evaluation of the MiniArc Single-Incision Sling System – The device delivered 91% success rate with the preliminary results pointing towards minimal estimated blood loss, minimal length of hospital stay and short operative times. American Medical Systems will continue evaluating results for up to twenty-four months.
• Six-month prospective evaluation of the Elevate Prolapse Repair System – The device demonstrated efficiency of 94.5% in posterior treatment and a 95.1% efficiency in apical treatment. The trial evaluated 139 patients with Stage II or greater prolapse at 16 U.S. and European sites.
• Twenty-four month study of the Perigee Prolapse Repair System – The device produced 88.5% success rate in 114 patients implanted with the system. This was a single-arm, prospective study conducted across 8 U.S. sites.

The new positive clinical data will boost sales of these products and eventually cater to the top-line growth. Headquartered in Minnetonka, MN, American Medical Systems is a world leader in medical devices and procedures used to treat erectile dysfunction and other men’s and women’s health problems.

The company competes with Johnson & Johnson (JNJ) and Boston Scientific Corporation (BSX).

Zacks Investment Research
View original at: Zacks.com News Feed

1. (ABT) Abbott Lab’s XIENCE V Presents Positive DataYesterday, Abbott (ABT) presented positive long-term data on the XIENCE V Everolimus Eluting Coronary Stent...
2. (AMMD) American Medical Systems Holdings Amends Notes ExchangeAmerican Medical Systems Holdings, Inc. (AMMD) amended its offer to exchange up to $250 million...
3. (BSX) Positive SYNTAX for Boston Scientific StentBoston Scientific Corporation (BSX) recently came out with its two-year SYNTAX clinical data that do...
4. (MMSI) Merit Medical Systems, Inc. – Aggressive Growth – Zacks Rank BuyMerit Medical Systems, Inc. (MMSI) boosted its net income by 28% in its latest earnings...
5. (AMMD) American Medical Services – Aggressive Growth – Zacks Rank BuyAmerican Medical Systems (AMMD) just beat the Street’s expectations and shares have surged in response....
6. American Medical Systems Holdings, Inc. – Aggressive Growth – Zacks Rank BuyAmerican Medical Systems (AMMD) just beat the Street’s expectations and shares have surged in response....

Search Posts by Tag: American Medical Systems Holdings Inc | AMMD | Boston Scientific Corporation | BSX | JNJ | Johnson & Johnson | SUI | Sun Communities Inc | Healthcare | Medical Appliances & Equipment

RSS Feeds by Tag: American Medical Systems Holdings Inc | AMMD | Boston Scientific Corporation | BSX | JNJ | Johnson & Johnson | SUI | Sun Communities Inc | Healthcare | Medical Appliances & Equipment |

Other Posts by: vitalstocks | RSS Feed for this author